Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Thermo Fisher Scientific (TMO) 10K Form and Latest SEC Filings 2026

Thermo Fisher Scientific logo
$448.55 -0.82 (-0.18%)
Closing price 03:59 PM Eastern
Extended Trading
$448.62 +0.07 (+0.02%)
As of 06:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Thermo Fisher Scientific SEC Filings & Recent Activity

Thermo Fisher Scientific (NYSE:TMO) has submitted 753+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Thermo Fisher Scientific's financial statements. The most recent filing was a Form 4 submitted on May 22, 2026.

Form 4
THERMO FISHER SCIENTIFIC INC. Reports Ownership Change on Mar. 31, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Thermo Fisher Scientific Files Current Report on Apr. 23, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Thermo Fisher Scientific Files Quarterly Report on May. 1, 2026

The 10-Q contains Thermo Fisher Scientific's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Thermo Fisher Scientific SEC Filing History

Browse Thermo Fisher Scientific's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/11/2026 6:30 AM
Thermo Fisher Scientific (97745) Filer
Form DEFA14A
05/01/2026 10:00 AM
Thermo Fisher Scientific (97745) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2026 12:58 PM
Thermo Fisher Scientific (97745) Subject
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Form SCHEDULE 13G
04/27/2026 8:58 AM
Pettiti Gianluca (1844600) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/23/2026 5:03 AM
Thermo Fisher Scientific (97745) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2026 7:14 AM
Thermo Fisher Scientific (97745) Filer
Form DEF 14A
04/07/2026 7:16 AM
Thermo Fisher Scientific (97745) Filer
Form DEFA14A
04/07/2026 7:16 AM
Thermo Fisher Scientific (97745) Filer
Form ARS
03/31/2026 3:58 PM
Thermo Fisher Scientific (97745) Issuer
WEISLER DION J (1580693) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2026 3:59 PM
JOHNSON JENNIFER M (1010270) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2026 4:01 PM
Lynch Karen S (1333760) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2026 4:02 PM
Keith R. Alexandra (1710268) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2026 4:03 PM
SPERLING SCOTT M (1214212) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2026 12:36 PM
Thermo Fisher Scientific (97745) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/24/2026 7:02 AM
Thermo Fisher Scientific (97745) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2026 3:23 PM
Shafer Michael D (2020619) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2026 9:28 AM
Shafer Michael D (2020619) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2026 3:07 PM
Meyer James (2115686) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/09/2026 3:39 PM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 3:53 PM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 9:19 AM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2026 9:25 AM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2026 11:23 AM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2026 9:43 AM
Thermo Fisher Scientific (97745) Subject
Williamson Stephen (1648929) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 3:18 PM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 3:01 PM
Lowery Frederick M. (1777440) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 4:08 PM
Britt Lisa P. (1676320) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 4:11 PM
Lagarde Michel (1518973) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 4:13 PM
Thermo Fisher Scientific (97745) Issuer
Williamson Stephen (1648929) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 11:11 AM
Thermo Fisher Scientific (97745) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2026 3:19 PM
Thermo Fisher Scientific (97745) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2026 4:02 PM
Thermo Fisher Scientific (97745) Filer
Form 424B5
02/09/2026 4:25 PM
Thermo Fisher Scientific (97745) Subject
Form FWP
02/09/2026 9:18 AM
Pettiti Gianluca (1844600) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2026 7:09 AM
Thermo Fisher Scientific (97745) Filer
Form 424B5
01/29/2026 5:02 AM
Thermo Fisher Scientific (97745) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2026 8:32 AM
NEW YORK STOCK EXCHANGE LLC (876661) Filed by
Thermo Fisher Scientific (97745) Subject
Form 25-NSE
01/21/2026 9:05 AM
NEW YORK STOCK EXCHANGE LLC (876661) Filed by
Thermo Fisher Scientific (97745) Subject
Form 25-NSE
01/12/2026 5:02 AM
Thermo Fisher Scientific (97745) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2026 4:13 PM
Lynch Karen S (1333760) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 4:03 PM
JOHNSON JENNIFER M (1010270) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th... (Ad)

After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall of Fame Trader Jon Najarian now says EVERYONE is missing an even bigger story about the SpaceX IPO… That it's just the start of an Elon Musk $44 trillion "Superconvergence…" An event that could kick off as soon as June 12th.tc pixel

Click here now to watch hall of fame trader Jon Najarian's full prediction.
12/08/2025 12:03 PM
Thermo Fisher Scientific (97745) Filer
Form CERT
12/05/2025 3:40 PM
Lagarde Michel (1518973) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 3:46 PM
Lagarde Michel (1518973) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 10:03 AM
Lagarde Michel (1518973) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2025 3:48 PM
Lowery Frederick M. (1777440) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 3:50 PM
Shropshire Thomas B Jr. (2070785) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 2:53 PM
Lagarde Michel (1518973) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2025 2:29 PM
Lagarde Michel (1518973) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2025 9:00 AM
Lowery Frederick M. (1777440) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2025 3:15 PM
Thermo Fisher Scientific (97745) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2025 3:19 PM
Thermo Fisher Scientific (0) Finance I
Thermo Fisher Scientific (97745) Filer
Form 8-A12B
12/01/2025 9:37 AM
Lowery Frederick M. (1777440) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2025 4:24 PM
Shafer Michael D (2020619) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2025 1:29 PM
Shafer Michael D (2020619) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/24/2025 3:51 PM
Thermo Fisher Scientific (97745) Subject
Form FWP
11/24/2025 5:02 AM
Thermo Fisher Scientific (0) Finance I
Thermo Fisher Scientific (97745) Filer
Form 424B5
11/17/2025 3:32 PM
Thermo Fisher Scientific (97745) Issuer
Williamson Stephen (1648929) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2025 3:47 PM
Lagarde Michel (1518973) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2025 10:46 AM
Lagarde Michel (1518973) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2025 4:06 PM
Britt Lisa P. (1676320) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/10/2025 3:51 PM
Britt Lisa P. (1676320) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2025 9:30 AM
Pettiti Gianluca (1844600) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2025 4:13 PM
Britt Lisa P. (1676320) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2025 8:36 AM
Thermo Fisher Scientific (97745) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2025 5:05 AM
Thermo Fisher Scientific (97745) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2025 3:31 PM
Pettiti Gianluca (1844600) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2025 3:17 PM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/24/2025 3:10 PM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/24/2025 8:41 AM
Pettiti Gianluca (1844600) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2025 5:05 AM
Thermo Fisher Scientific (97745) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2025 3:30 PM
Thermo Fisher Scientific (97745) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2025 4:03 PM
Thermo Fisher Scientific (97745) Filer
Form 424B5
09/30/2025 3:14 PM
Keith R. Alexandra (1710268) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2025 3:17 PM
SPERLING SCOTT M (1214212) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2025 3:19 PM
Thermo Fisher Scientific (97745) Issuer
WEISLER DION J (1580693) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2025 8:01 AM
Thermo Fisher Scientific (97745) Filer
Form 424B5
09/09/2025 3:38 PM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 4:39 PM
Britt Lisa P. (1676320) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 4:41 PM
Pettiti Gianluca (1844600) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 4:45 PM
Holmes Joseph R. (1839832) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 4:48 PM
Lagarde Michel (1518973) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 4:51 PM
Lowery Frederick M. (1777440) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 4:53 PM
Shafer Michael D (2020619) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 4:55 PM
Thermo Fisher Scientific (97745) Issuer
Williamson Stephen (1648929) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 4:58 PM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 7:03 AM
Thermo Fisher Scientific (97745) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2025 11:47 AM
Holmes Joseph R. (1839832) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2025 3:32 PM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2025 3:37 PM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2025 3:24 PM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
The SpaceX supplier that shipped 5 billion chips to Starlink (Ad)

When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, supplier Broadcom gained 15,000%. The pattern is clear: suppliers often dwarf the headline stock. One little-known company has shipped over 5 billion chips to SpaceX - a figure expected to reach 10 billion by 2027. SpaceX calls them 'instrumental to Starlink's success.' With the IPO expected in June, you can get the name, ticker, and a full year of tech research for just $19 - 85% off.tc pixel

Get the name and ticker before the SpaceX IPO arrives
08/19/2025 9:36 AM
Boxer Michael A (1726596) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2025 6:14 PM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2025 11:26 AM
CASPER MARC N (1216055) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2025 9:41 AM
Thermo Fisher Scientific (97745) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/28/2025 3:43 PM
Pettiti Gianluca (1844600) Reporting
Thermo Fisher Scientific (97745) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025 11:12 AM
Pettiti Gianluca (1844600) Reporting
Thermo Fisher Scientific (97745) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2025 5:03 AM
Thermo Fisher Scientific (97745) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2025 1:30 PM
Thermo Fisher Scientific (97745) Filer
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
05/30/2025 6:32 AM
Thermo Fisher Scientific (97745) Filer
Form SD
Specialized Disclosure Report  
(Data available from 1/1/2016 forward)

Thermo Fisher Scientific SEC Filings - Frequently Asked Questions

Thermo Fisher Scientific (TMO) has submitted 753+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Thermo Fisher Scientific's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Thermo Fisher Scientific's financial statements page.

The most recent filing was a Form 4 submitted on May 22, 2026. This was an insider ownership change filed by 4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:TMO) was last updated on 5/22/2026 by MarketBeat.com Staff.
From Our Partners